Clinical Trial Update: Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations [Phase 3]

View source ↗

Summary

Phase 3 trial update for a bleed-free, ultra-low-dose hormonal combination aimed at menopausal vasomotor symptoms; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopausal Vasomotor Symptoms
• Menopause

Drugs mentioned

• Ultra Low Dose Hormonal Combination

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Menopause, Menopausal Vasomotor Symptoms | Phase 3 | Status: COMPLETED